A Phase 3 Noninferiority Study Comparing the Efficacy, Immunogenicity, and Safety of Foligraf®: A Biosimilar Recombinant Human Follicle-stimulating Hormone and Gonal-f® (Prefilled Pen) in Subjects Undergoing Controlled Ovarian Stimulation for Assisted Reproductive Technology

Category Primary study
JournalInt. J. Infertil. Fetal. Med.
Year 2025
This article has no abstract
Epistemonikos ID: e3a457e4f91f5c8c9682202141e8827a25eadfbf
First added on: Jan 10, 2026